XHKG
1336
Market cap21bUSD
Oct 22, Last price
37.92HKD
1D
-4.00%
1Q
-21.62%
Jan 2017
6.52%
IPO
50.78%
Name
New China Life Insurance Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 1996 and headquartered in Beijing, People's Republic of China, New China Life Insurance Company Ltd. provides a wide array of life insurance products and related services to both individual clients and institutional organizations throughout China. The company structures its operations into three main categories: Individual Insurance Business, Group Insurance Business, and a segment for Other Business activities. In addition to its core insurance offerings, the firm diversifies its portfolio by providing asset management, educational training, electronic commerce, and medical services. It also actively participates in the real estate sector, undertaking investments, development projects, leasing arrangements, and property management.
Key people
Xingfeng Gong
President, Chief Financial Officer, Finance Director, Executive Director · since 2024
Hongbo Qin
Vice President · since 2024
Lianwen Wang
Vice President · since 2022
Yucheng Yang
Executive Chairman of the Board · since 2023
Wenfeng Li
Assistant to the President · since 2024
Chen Liu
Assistant to the President · since 2024
Xing Pan
Chief Actuary · since 2025
Zhiyong Liu
Assistant to the President, Secretary of Board · since 2025
Non-Executive Director · since 2016
Sixue Mao
Non-Executive Director · since 2025
Xue Yang
Non-Executive Director · since 2021
Non-Executive Director · since 2025
Yongqing Guo
Independent Director · since 2022
Xu Xu
Independent Director · since 2022
Xiufen Zhang
Independent Director · since 2025
Zhi Zhuo
Independent Director · since 2025
Headquarters & legal address
北京市延庆区湖南东路16号(中关村延庆园)
延庆县, BJ 100000
CN
延庆县, BJ 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||